Extensions of PSD-95/discs large/ZO-1 (PDZ) domains influence lipid binding and membrane targeting of syntenin-1  by Wawrzyniak, Anna Maria et al.
FEBS Letters 586 (2012) 1445–1451journal homepage: www.FEBSLetters .orgExtensions of PSD-95/discs large/ZO-1 (PDZ) domains inﬂuence lipid binding
and membrane targeting of syntenin-1
Anna Maria Wawrzyniak, Elke Vermeiren, Pascale Zimmermann ⇑, Ylva Ivarsson ⇑
Laboratory for Signal Integration in Cell Fate Decision, Department of Human Genetics, KU Leuven, Belgium
a r t i c l e i n f oArticle history:
Received 17 March 2012
Revised 10 April 2012
Accepted 12 April 2012
Available online 21 April 2012
Edited by Maurice Montal
Keywords:
PDZ
Phospholipids
Electrostatic interactions
Autoinhibition
Membrane targeting
Surface plasmon resonance0014-5793/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.febslet.2012.04.024
⇑ Corresponding authors. Address: Department of
Herestraat 49, Box 602, B-3000 Leuven, Belgium. Fax:
E-mail addresses: Pascale.zimmermann@med.kul
ylva.ivarsson@kimlab.org (Y. Ivarsson).a b s t r a c t
Syntenin-1 is a PDZ protein involved in receptor recycling and clustering. Its two PDZ domains inter-
act with various receptors and phosphoinositides, and are ﬂanked by N- and C-terminal regions.
Here, we report the identiﬁcation of an autoinhibitory peptide stretch in the N-terminus that might
be regulated by phosphorylation. We further establish that basic residues in the C-terminal region
mediate electrostatic interactions with reconstituted liposomes and contribute to the plasma mem-
brane targeting. Our study adds new components to the multi-dentate membrane targeting mech-
anism and highlights the role of N- and C-terminal PDZ extensions in the regulation of syntenin-1
plasma membrane localization.
Structured summary of protein interactions:
PDZ1-PDZ2 and peptide bind by ﬂuorescence technology (View Interaction: 1, 2, 3, 4).
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Scaffolding proteins provide spatiotemporal organization of sig-
naling complexes crucial for accurate ﬂow of cellular information
[1]. They are composed of modular domains linked and ﬂanked
by unstructured regions, and generally lack catalytic activity. Their
proper distribution is commonly achieved by interactions with
membrane receptors and/or membrane lipids [2]. The negative
electrostatic potential of the plasma membrane plays a pivotal role
in the recruitment of proteins containing poly-basic clusters [3–5].
The plasma membrane is enriched in phosphatidylinositol 4,5-bis-
phosphate (PIP2) which regulates, among other processes, actin
polymerization and vesicular trafﬁcking [6]. At physiological pH,
PIP2 carries a net charge of ca. 4 and contributes thereby to the
negative surface charge of the inner leaﬂet of the plasma mem-
brane. Phosphatidylserine (PS) is the most abundant anionic
phospholipid in the inner leaﬂet and carries one negative charge
at pH 7 [7].
PDZ (postsynaptic density protein-95/discs large/zonula occlu-
dens-1) domains are among the most common protein–protein
interaction modules in multi-cellular organisms. They are involved
in a variety of cellular processes including establishment andchemical Societies. Published by E
Human Genetics, KU Leuven,
+32 16 330817.
euven.be (P. Zimmermann),maintenance of cell polarity [8]. PDZ domains are composed of
80–90 amino acids with a common fold comprising six b-strands
and two a-helices. They commonly recognize the C-terminal pep-
tides of their target proteins, but may also interact with internal
peptide stretches, hetero- and homo-dimerize and/or interact with
phosphoinositides [9,10]. Syntenin-1 is a scaffolding protein con-
taining two PDZ domains. The PDZ domains can accommodate a
wide range of C-terminal peptide ligands [11] and the plasticity
of peptide binding speciﬁcity allows syntenin-1 to interact with a
range of mainly transmembrane receptors including syndecans
[12] and Frizzled-7 [13]. Syntenin-1 can also interact with plasma
membrane PIP2, an interaction attributed to the PDZ-tandem. In-
deed, syntenin-1 was the paradigm example of a PIP2-PDZ interac-
tion [14]. The importance of the syntenin-1-PIP2 interaction was
demonstrated in cellulo for the recycling of syndecans and cell
spreading, and in vivo for directional movements in zebraﬁsh
[15,16].
While several functional studies have elucidated the functional
importance of the PDZ-tandem, only few studies have been focused
on the unstructured N- and C-terminal regions. The ca. 100 amino
acid long N-terminal domain (NTD) has been proposed to hold an
autoinhibitory region [11,17], recruit Sox4 [18] and to interact
with ubiqitin [19,20]. The C-terminal extension (CTD) consisting
of ca. 20 residues has in several cases been found to be a necessary
extension of the PDZ tandem for high afﬁnity interactions [21,22].
In this study we aimed to elucidate how, and to what extent, the
NTD and the CTD of syntenin-1 regulate and contribute to itslsevier B.V. All rights reserved.
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itory peptide stretch in the NTD that interacts with the PDZ-
tandem; an interaction that may be regulated by a tyrosine
phosphorylation switch. We discovered that basic residues in the
CTD contribute to electrostatic interactions crucial for plasma
membrane targeting and established that such interactions rely
on the negative plasma membrane potential built up by PS. The re-
sults illustrate the importance of N- and C-terminal extensions in
regulating and contributing to syntenin-1 function.
2. Materials and methods
2.1. Molecular biology
eGFP-Syntenin-1 and eYFP-PDZ1-PDZ2-CTD constructs were
described previously [17]. The fragments encoding PDZ1-PDZ2-
CTD (amino acids 103–298) or PDZ1-PDZ2 (103–275) were ampli-
ﬁed by PCR using oligonucleotides carrying the restriction sites for
NcoI and EcoRI (Roche) and subcloned into the pETM-11 plasmid
(EMBL Heidelberg) for the expression of N-terminally His-tagged
proteins. Site-directed mutagenesis was performed using Quik-
Change (Stratagene) on the eGFP-, eYFP- or pETM-11-templates.
All constructs were veriﬁed by DNA sequencing.
2.2. Cell culture, transfections and microscopic analysis
MCF-7 cells obtained from American Type Culture Collection
(Manassas, VA) were cultured in DMEM/F-12 medium (Life Tech-
nologies) supplemented with 10% fetal bovine serum (Gibco). For
microscopy experiments cells were plated on eight-well chamber
slides (Nagle Nunc International, Roche) and transfected after 4 h
with FuGENE (Roche). Confocal images were obtained 10 h after
transfection with an Olympus Fluoview 1000 microscope (Olym-
pus) using appropriate ﬁlter sets. The enrichment of ﬂuorescently
tagged constructs at the plasma membrane was scored in living
cells by wide-ﬁeld microscopy (Leica AS-MDW) in at least 30 cells
for each condition in three independent experiments. Cells with
comparable ﬂuorescence were selected for quantiﬁcations. Mean
grey values were typically between 700 and 1600 (see also Supple-
mentary Table 1). Myc-tagged PtdInsP 5 kinase was visualized
using anti-Myc antibody (9E10, Sigma–Aldrich) and Alexa 647-
conjugated goat anti-mouse secondary antibody (Invitrogen) and
the staining was performed as described previously [17]. For dibu-
caine treatment, cells were incubated in a synthetic medium con-
taining 150 mMNaCl, 5 mM KCl, 1 mMMgCl2, 100 lM EGTA, 2 mM
CaCl2, and 20 mM HEPES, pH 7.4 and dibuciane (Sigma–Aldrich)
was added to the ﬁnal concentration of 1 mM for 30 min at 37 C.
2.3. Protein puriﬁcations
N-terminally his-tagged syntenin-1 variants were expressed in
Escherichia coli ER2566 and puriﬁed by nickel afﬁnity chromatogra-
phy as described previously [23].Table 1
Apparent afﬁnities for 5% PIP2 in the background of composite liposomes (30% PC/20%
PS/40% PE/5% PI and 5% PIP2) as determined by SPR binding experiments.
Apparent KPIP2D (lM)
PDZ1-PDZ2 44 ± 12
PDZ1-PDZ2-CTD 11 ± 2
PDZ1-PDZ2-CTD/K280A/R281A 50 ± 9
PDZ1-PDZ2-CTD/K280A/R281A/M282R/A283R 8 ± 1
PDZ1-PDZ2-CTD/M282R/A283R 10 ± 2
PDZ1-PDZ2-CTD/S285D/S289D 28 ± 42.4. Peptide binding experiments
Peptide binding experiments were performed in 150 mM NaCl,
25 mM HEPES, 1 mM DTT, pH 7.2 using a Cary Eclipse Spectroﬂuo-
rimeter (Varian) at 25 C, essentially as previously described [23].
Synthetic peptides (ELSQYMGLSL-NH2 and ELSQEMGLSL-NH2)
were from GeneCust and of high purity (>95%). PDZ1-PDZ2,
PDZ1-PDZ2/G126E and PDZ1-PDZ2/G210D (3 lM) were titrated
with increasing peptide concentrations (10–800 lM), and the
change in intrinsic tryptophan ﬂuorescence was recorded (excita-
tion at 280 nm, emission at 320–380 nm). The observed signal
was corrected for background by subtraction of the signal recorded
when performing the same titration in the absence of proteins. The
observed transitions were ﬁtted by simple binding isotherms using
Prism (GraphPad). The experiments were repeated independently
three times.
2.5. SPR experiments
SPR experiments were performed with a Biacore T100 (GE
Healthcare). Bulk phospholipids (phosphatidyl cholin (PC), PS,
phosphatidyl ethanolamine (PE) and 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC)) were from Sigma–Aldrich. PI and PIP2
were from Echelon Biosciences. Composite liposomes (30% PC/
20% PS/40% PE/5% PI and 5% PIP2 or 10% PI for background refer-
ence) or DOPC liposomes (95% DOPC/5% PIP2 or 5% PI for back-
ground reference, or 80% DOPC/20% PS with 100% DOPC for
background reference) were prepared and immobilized as de-
scribed previously [24] in 150 mM NaCl, 25 mM HEPES, 1 mM
DTT, pH 7.2. Liposomes were coated on L1 chips, with immobiliza-
tion levels of 5000–6000 RU. Proteins were freshly prepared, dia-
lyzed against the running buffer and injected at seven different
concentrations. The surface was regenerated between runs by
two 30 s pulses of 50 mM NaOH. The ﬂow was 30 lL/min, the tem-
perature 25 C, and the injection time 240 s. Sensorgrams were
double reference subtracted (e.g. PI-liposomes and buffer effect)
and the responses observed 5 s before injection stop were plotted
as a function of protein concentrations. Apparent KD values were
determined by ﬁtting the data to a 1:1 Langmuir binding isotherm
(GraphPad Prism). The experiments were repeated using different
batches of liposomes and proteins.3. Results
3.1. Identiﬁcation of the autoinihibitory element in the NTD
The syntenin-1 NTD has been proposed to work as an autoin-
hibitory region because ﬂuorescently tagged full length syntenin-
1 (eGFP-syntenin-1) is mainly diffused upon over-expression in
MCF-7 cells, on the contrary to syntenin-1 with the NTD deleted,
which is highly enriched at the plasma membrane [17]. Indeed,
discrete plasma membrane enrichment of full length syntenin-1
is found in only 17% of transfected cells (Fig. 1A, B and G;) and dele-
tion of the ﬁrst 102 amino acids confers a strong plasmamembrane
enrichment of the protein in all cells (eYFP-PDZ1-PDZ2-CTD)
(Fig. 1C and G). To identify the autoinhibitory element, we made
truncation variants of the ﬂuorescently tagged protein (Fig. 1)
and quantiﬁed the plasma membrane enrichment of the con-
structs. Truncation of the NTD from amino acid 1–51 did not im-
prove the membrane enrichment (Fig. 1D and G). However, when
truncated at amino acid 57, or further, the protein became strongly
enriched at the plasma membrane (Fig. 1E and G). The region be-
tween amino acids 56 and 59 is highly conserved among synte-
nin-1 proteins (Fig. 1H). We hypothesized that the peptide
stretch could interact with the PDZ-tandem and probed for a direct
Fig. 1. Autoinhibition by intramolecular interactions regulates plasma membrane targeting of syntenin-1. (A) Syntenin-1 contains two PDZ domains ﬂanked by the NTD and
CTD predicted to be largely unstructured. (B–F) Confocal images of syntenin-1 variants over-expressed in MCF-7 cells: eGFP-syntenin-1 (B); eYFP-PDZ1-PDZ2-CDT (C); eGFP-
D51-syntenin-1 (D); eGFP-D57-syntenin-1 (E); eGFP-syntenin-1/Y56E (F). (G) Bar graph of the mean percentage of cells (± SD) where syntenin-1 variants (shown on the left
panel) were enriched at the plasma membrane. (H) Alignment of the conserved region in the syntenin-1 NTD holding the autoinhibitiory region. (I) Structure of PDZ1-PDZ2 in
cartoon representation (Pymol). PDZ1 is indicated in red and PDZ2 in blue. Trp169 (yellow space ﬁll representation) was used as a ﬂuorescent probe in peptide binding
experiments. Gly126 and Gly210 (black space ﬁll) in the carboxylate binding region of PDZ1 and PDZ2, respectively, were probed by mutagenesis. (J) Equilibrium titration of
recombinant PDZ1-PDZ2 with synthetic wild-type (ELSQYMGLSL-NH2, blue) and phosphomimetic mutant (ELSQEMGLSL-NH2, red) peptides (left panel) and recombinant
PDZ1-PDZ2/G126E (red) and PDZ1-PDZ2/G210D (blue) with the ELSQYMGLSL-NH2 peptide (right panel) as followed by change in intrinsic tryptophane ﬂuorescence.
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10mer peptide (ELSQYMGLSL-NH2) following the quenching of
the intrinsic ﬂuorescence of Trp167 (Fig. 1J). The observed transi-
tions were ﬁtted by a simple binding isotherms yielding a KD of
130 ± 30 lM, thus supporting a direct interaction between the
internal peptide stretch and PDZ1-PDZ2. To establish which of
the two PDZ domains mediated the interaction, we mutated the
peptide binding sites of PDZ1 (G126E) and PDZ2 (G210D)
(Fig. 1I) [25]. The afﬁnities of the mutant proteins for the ELS-
QYMGLSL-NH2 peptide was determined to 330 ± 40 lM and
146 ± 40 for PDZ1-PDZ2/G126E and PDZ1-PDZ2/G210D, respec-
tively, indicating that the carboxylate binding groove of PDZ2 is
not involved in the interaction (Fig. 1J).
The Group-based Prediction System GPS2.1 [26] predicts that
Tyr56 in the conserved peptide stretch is a potential phosphoryla-
tion site. We therefore investigated whether Tyr56 phosphoryla-
tion could modulate the strength of the interaction between theinternal peptide stretch and PDZ1-PDZ2. Consistent with such reg-
ulation, the afﬁnity of PDZ1-PDZ2 for a synthetic phosphomimetic
mutant peptide (ELSQEMGLSL-NH2) was three times lower than
for the wild-type peptide (340 ± 60 lM) (Fig. 1J) and a phosphom-
imetic eGFP-syntenin-1/Y56E construct was found to be strongly
enriched at the plasma membrane (Fig. 1F and G). The in cellulo
and in vitro data thus suggest that phosphorylation of Tyr56 may
regulate the plasma membrane association of syntenin-1.
3.2. PDZ1-PDZ2 and the CTD form a functional unit
It was originally suggested that the PDZ tandem of syntenin-1
forms a supramodule as both PDZ domains were necessary for
plasma membrane localization [17]. What was not investigated
at the time was the contribution of the CTD that made part of
the expression construct (eYFP-PDZ1-PDZ2-CTD). To investigate
to what extent the CTD contributes to the membrane targeting,
Fig. 2. Membrane electrostatics in charge of targeting of syntenin-1. (A-H) Confocal images of syntenin-1 variants over-expressed in MCF-7 cells: eYFP-PDZ1-PDZ2 (A); eYFP-
PDZ2-CTD (B); eYFP-PDZ1-PDZ2-CTDD278 (C); eYFP-PDZ1-PDZ2-CTDD281 (D); eYFP-PDZ1-PDZ2-CTD K280A/R281A (E); eYFP-PDZ1-PDZ2-CTD K280A/R281A/M282K/
A283R (F); eYFP-PDZ1-PDZ2-CTD M282K/A283R (G); eYFP-PDZ1-PDZ2-CTD S285D/S289D (H); I Bar graph of the mean percentage of cells (±S.D.) where syntenin-1 variants
(shown on the left panel) were enriched at the plasma membrane. (J) Alignment of the CTD of syntenin-1 that contains conserved basic residues (red) and two potential serine
phosphorylation sites (blue). (K) Confocal images of MCF-7 cells expressing R-pre-mRFP, reporter for surface charge; eYFP-PH-PLC, probe for the plasma membrane PIP2 and
eYFP-PDZ1-PDZ2-CTD syntenin-1 in control (left panel) and in cell treated with 1 mM dibucaine (right panel). Note lost of the plasma membrane localization in case of R-pre-
mRFP and eYFP-PDZ1-PDZ2-CTD syntenin-1.J. (L) Double reference subtracted sensorgrams for 25 lM recombinant proteins injected over 5% PIP2 (left) or 20% PS in DOPC
liposomes (right). (M) Binding isotherms of recombinant syntenin-1 variants with 5% PIP2 in the background of composite liposomes intended to mimic the lipid composition
of the plasma membrane.
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analyzed their subcellular localizations upon transient over-
expression in MCF-7 cells. Surprisingly, truncation of the full CTD
(residues 276–298) conferred a complete loss of membrane local-
ization of eYFP-PDZ1-PDZ2 (Fig. 2A and I) indicating that the PDZ
tandem is not of high enough afﬁnity for conferring membrane
localization in quiescent cells. Truncation of the ﬁrst PDZ domain
from the expression construct (eYFP-PDZ2-CTD) similarly resulted
in a disperse ﬂuorescence (Fig. 2B and I), and even an increase in
the plasma membrane PIP2 levels by co-expression of PtdInsP 5 ki-
nase or overexpression of syntenin-1 peptide ligand, failed to tar-
get the protein to the membrane (data not shown). Taken
together the data suggest that PDZ1-PDZ2 and the CTD cooperatein the plasma membrane targeting and that the CTD is important,
but not sufﬁcient, for plasma membrane targeting.
To identify the molecular determinants in the CTD involved in
plasma membrane targeting we made alternative truncation
constructs of eYFP-PDZ1-PDZ2-CTD introducing stop codons
after amino acids 278 and 281 (eYFP-PDZ1-PDZ2-CTD/D278 and
eYFP-PDZ1-PDZ2-CTD/D281). While the ﬁrst construct was dif-
fused (Fig. 2C and I), the second construct was strongly enriched
at the plasma membrane (Fig. 2D and I). The conserved three
amino acid stretch between 278 and 281 contains two basic
resides Lys280 and Arg281 (Fig. 2J), and such positively charged
residues may contribute with electrostatic interactions reinforcing
the membrane targeting [5]. We therefore made a double mutant
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placed by Ala (eYFP-PDZ1-PDZ2-CTD/AA). The plasma membrane
enrichment of eYFP-PDZ1-PDZ2-CTD/AA was diminished, with
only 18% of the cells displaying membrane localization of the ﬂuo-
rescently tagged protein (Fig. 2E and I). We hypothesized that the
positive charges of Lys280 and Arg281, rather than the speciﬁc
positions were required for plasma membrane enrichment, and
probed it by shifting the position of the charges by two amino
acids. Consistently, the double mutant M282K/A283R in the back-
ground of eYFP-PDZ1-PDZ2-CTD/AA (eYFP-PDZ1-PDZ2-CTD/AAKR)
was found to be strongly enriched at the plasma membrane (Fig. 2F
and I). Finally, we made a double mutant M282K/A283R in the
background of wild-type eYFP-PDZ1-PDZ2 (eYFP-PDZ1-PDZ2-
CTD/KR) and the increase in positive net charge resulted in a strong
enrichment of the construct at the plasma membrane (Fig. 2G and
I). Our observations thus support a model where the basic residues
K280/R281 in the CTD contribute with electrostatic interactions
necessary for plasma membrane targeting of syntenin-1.
The contribution of electrostatic interactions in membrane tar-
geting is commonly regulated by phosphorylation of adjacent res-
idues [27]. We therefore scanned the CTD using GPS2.1, which
identiﬁed Ser285 and Ser289 as potential phosphorylation sites.
We generated a phosphomimetic double mutant replacing
Ser285 and Ser289 with Asp (eYFP-PDZ1-PDZ2-CTD/DD). The plas-
ma membrane enrichment of eYFP-PDZ1-PDZ2-CTD/DD was re-
duced as compared to wild-type eYFP-PDZ1-PDZ2-CTD, with 44%
of cells displaying strong membrane localization (Fig. 2H and I),
supporting that charge alterations of the CTD may regulate synte-
nin-1 plasma membrane localization.
3.3. Changes of the plasma membrane surface potential may regulate
subcellular targeting of syntenin-1
The importance of PIP2 for membrane targeting of syntenin-1
was originally demonstrated by ionomycin treatment [14] which
induces breakdown of plasma membrane PIP2 by activation of
phospholipase C. However, ionomycin also lowers the negative
charge of the inner leaﬂet of the plasma membrane by promoting
scrambling of PS from the inner to the outer leaﬂet and shielding
the negative charges by calcium cations [28]. We therefore tested
to what extent the mere negative potential of the plasmaFig. 3. Multi-component membrane targeting of syntenin-1 and potential phosphorylat
peptide and phospholipid interactions mediated by the PDZ tandem and positive charge
(A), which might be regulated by a phosphorylation switch (B). Phosphomimetic mut
phosphorylation in this region (C).membrane contributes to syntenin-1 targeting using dibucaine.
Dibucaine is a cationic amphiphile that promotes scrambling of
PS and inserts into the plasma membrane resulting in the reduc-
tion of the net charge [29,30]. The effect of the dibucaine treatment
was validated using R-pre-mRFP (Fig. 2K), a reporter for surface
charge, developed by Yeung and co-workers [30]. After dibucaine
treatment, eYFP-PD1-PDZ2-CTD was found dissociated from the
plasma membrane in 57 ± 7% of cells, as compared to 13 ± 4% of
cells before treatment (Fig. 2K). Importantly, PIP2 was still present
at the membrane as eYFP-PH–PLC, a well-established probe for
plasma membrane PIP2 [31], remained associated with the mem-
brane (Fig. 2K). The data thus suggest electrostatic interactions be-
tween the protein surface and the negatively charged plasma
membrane reinforce the peptide/PIP2 driven membrane targeting
of syntenin-1, and that such interactions may be modulated by
alterations of either the net charge of the protein or the plasma
membrane.
3.4. In vitro binding experiments conﬁrm the in cellulo ﬁndings
We validated our in cellulo ﬁndings by in vitro binding experi-
ments using recombinant his-tagged proteins in SPR experiments.
We injected the proteins (25 lM) over 5% PIP2 or 20% PS incorpo-
rated in neutral DOPC liposomes (Fig. 2L). The sensorgrams were
corrected for binding to the reference 100% DOPC liposomes and
for buffer effects (double reference subtracted). The proteins asso-
ciated with both PIP2 and PS containing liposomes, with signiﬁ-
cantly higher binding levels for PIP2. Consistent with the in
cellulo data, PDZ1-PDZ2-CTD displayed strikingly higher binding
levels than the truncated PDZ1-PDZ2, thus conﬁrming the impor-
tance of the CDT in reinforcing the interactions with anionic lipids.
A decrease of the net charge of the CTD by the PDZ-PDZ2-CTD/AA
and PDZ-PDZ2-CTD/DD mutations conferred a decrease in binding
levels, while restoring or increasing the net charge of the CTD by
the PDZ-PDZ2-CTD/AAKR or PDZ-PDZ2-CTD/KR mutations led to
increased binding levels. The binding levels of most proteins did
not reach saturating levels at the protein concentrations used,
which prevented KD determinations; the limit being the solubility
of the proteins. We therefore investigated the interactions between
the proteins and 5% PIP2 presented in the background of composite
liposomes mimicking the composition of the inner leaﬂet of theion switches. Syntenin-1 is targeted to the plasma membrane by a combination of
s in the CTD. An autoinhibitory N-terminal region restricts the membrane targeting
ants in the CTD suggest that the membrane targeting could be ﬁne-tuned by the
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(Fig. 2M). The observed apparent PIP2 afﬁnities were signiﬁcantly
higher in this context, suggesting a synergy between PIP2 and PS
binding, and allowing determinations of apparent KD values
(Table 1). The apparent afﬁnities of PDZ1-PDZ2-CTD, PDZ1-PDZ2-
CTD/AAKR and PDZ1-PDZ2-CTD/KR for PIP2 containing composite
liposomes were about 4 times higher than those of PDZ1-PDZ2
and PDZ-PDZ2-CTD/AA conﬁrming the importance of the basic res-
idues in the CTD in modulating the afﬁnity for anionic lipids.
4. Discussion
Syntenin-1 is involved in important biological functions such as
receptor clustering [32], trafﬁcking of transmembrane receptors
[15], and activation of the transcription factor Sox4 [18], and regu-
lates thereby the output of various signaling networks. The revers-
ible association of syntenin-1 with the plasmamembrane is critical
for its biological function. Our results suggest that syntenin-1 exist
in equilibrium between an open and a closed conformation,
(Fig. 3A). The intra-molecular interaction could serve to compete
with binding to inter-molecular ligands thereby providing the pro-
tein with a dynamic and ﬁne-tuned regulation of its binding prop-
erties. Autoinhibition have been previously described for PDZ
proteins such as X11a/Mint1 and NHERF1, in these cases being
conferred by interactions with the C-termini [33,34]. The close-
to-open equilibrium of syntenin-1 could be shifted towards the
open state by a Tyr56 phosphorylation (Fig. 3B); such phosphory-
lation may involve Src family kinases as the region around Tyr56
resemble the immunoreceptor tyrosine-based activation motif
(Yxx[L/I]x(6-12)Yxx[L/I]) and there is a direct interaction between
syntenin-1 and c-Scr [35]. However, whether and to what extent
Tyr56 phosphorylation regulates syntenin-1 function in cellulo re-
quires further experimental investigations.
Previous studies have suggested that syntenin-1 may be tar-
geted to the plasma membrane by PDZ-mediated peptide and/or
PIP2 interactions [14]. We here demonstrate that electrostatic
interactions between the negatively charged plasma membrane
and two basic residues in the C-terminal extension contribute to
the membrane targeting of syntenin-1. PDZ domains extensions
have in various cases been suggested to contribute to the function
of the PDZ domains, as reviewed recently [36]. For example, the
extension of the nNOS PDZ is required for complex assembly
[37]. The N-terminal extension of MAGI1 PDZ1 was recently found
to take a deﬁned secondary structure that prevents homodimer
formation and the C-terminal extension of the same PDZ domain
was shown to inﬂuence the afﬁnity of the peptide ligand [38]. Fur-
thermore, the helical extension of PSD-95 PDZ3 affect the afﬁnity
of the PDZ domain for the CRIPT peptide suggestively by hidden
dynamic allostery [39], while bioinformatic analysis recently sug-
gested that a set of key contacts between the b2-b3 loop and the
helical extension stabilize the apo form of the PSD-95 PDZ3 do-
main [40]. It is thus becoming evident that extensions of PDZ do-
mains have more functions than merely acting as linker regions
and our study adds a new functionality.
The multi-component targeting of syntenin-1 allows for dy-
namic and combinatorial regulation of its function by receptor
(de)phosphorylation [41], by change of the net plasma membrane
charge or by phosphorylation of the protein (Fig. 3C). The results
are in line with data on K-Ras that associates with the plasma
membrane through a dual binding motif (farnesylation paired with
a polybasic cluster); an association that can be abolished either by
modulating the surface potential of the protein surface through
phosphorylation [42] or by changes of the net charge of the plasma
membrane [43]. The multi-component membrane targeting of syn-
tenin-1 paired with autoinhibition, is further reminiscent of themultiple signal integration for protein such as N-WASP [44] and
the Ras guanine nucleotide exchange factor SOS [45] and should al-
low syntenin-1 to respond to diverse signaling inputs in a crowded
cellular environment while preventing inappropriate activation.
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